APO RESEARCH · REPORT
5% Dextrose Injection
5% Dextrose Injection refers to medicinal, supplement or research preparations identified by the named composition or biological target.

Product & engineering
Understand the product.
Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.
What turns activity into demand
Distinguish equipment procurement, recurring materials and any related service within the selected study. Research use, educational use and clinical use have different acceptance requirements and should not be treated as one demand measure.
The commercial boundary
Separate research materials, devices and services within the selected edition. Approvals, labelled use and clinical acceptance need their own evidence; no medical suitability follows from this illustration.
Which supplied scope and interfaces define 5% Dextrose Injection?
Identity, formulation, stock form, controls and documented use define the preparation; market categories and images do not establish approval, dosing or patient suitability.
Selected research
Market Structure
Global 5% Dextrose Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global 5% Dextrose Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for 5% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for 5% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for 5% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for 5% Dextrose Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of 5% Dextrose Injection include Pfizer, Fresenius Kabi, Baxter, Schwitz Biotech, Sanbao (GH) Pharmaceutical, Otsuka Pharmaceutical, Drugfield Pharmaceuticals Limited, B. Braun Medical Inc and Alfa Laboratories, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global 5% Dextrose Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of 5% Dextrose Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents 5% Dextrose Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the 5% Dextrose Injection market size, projected growth trends, production technologies, key applications, and end-use industries.
5% Dextrose Injection Segment by Company
Pfizer
Fresenius Kabi
Baxter
Schwitz Biotech
Sanbao (GH) Pharmaceutical
Otsuka Pharmaceutical
Drugfield Pharmaceuticals Limited
B. Braun Medical Inc
Alfa Laboratories
5% Dextrose Injection Segment by Type
500 mL
250 mL
1000 mL
5% Dextrose Injection Segment by Application
First-Aid Treatment
Sports
Trophotherapy
Others
5% Dextrose Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 5% Dextrose Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of 5% Dextrose Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 5% Dextrose Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the 5% Dextrose Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of 5% Dextrose Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of 5% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of 5% Dextrose Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 500 mL
- 250 mL
- 1000 mL
Applications
- First-Aid Treatment
- Sports
- Trophotherapy
- Others
Companies covered
- Pfizer
- Fresenius Kabi
- Baxter
- Schwitz Biotech
- Sanbao (GH) Pharmaceutical
- Otsuka Pharmaceutical
- Drugfield Pharmaceuticals Limited
- B. Braun Medical Inc
- Alfa Laboratories
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global 5% Dextrose Injection Market Size, 2021 VS 2025 VS 2032
- 1.3 Global 5% Dextrose Injection Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global 5% Dextrose Injection Sales Estimates and Forecasts (2021-2032)
- 1.5 Global 5% Dextrose Injection Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global 5% Dextrose Injection Market Dynamics
- 2.1 5% Dextrose Injection Industry Trends
- 2.2 5% Dextrose Injection Industry Drivers
- 2.3 5% Dextrose Injection Industry Opportunities and Challenges
- 2.4 5% Dextrose Injection Industry Restraints
3 5% Dextrose Injection Market by Manufacturers
- 3.1 Global 5% Dextrose Injection Revenue by Manufacturers (2021-2026)
- 3.2 Global 5% Dextrose Injection Sales by Manufacturers (2021-2026)
- 3.3 Global 5% Dextrose Injection Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global 5% Dextrose Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global 5% Dextrose Injection Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global 5% Dextrose Injection Manufacturers, Product Type & Application
- 3.7 Global 5% Dextrose Injection Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global 5% Dextrose Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 5% Dextrose Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 5% Dextrose Injection Tier 1, Tier 2, and Tier 3
4 5% Dextrose Injection Market by Type
- 4.1 5% Dextrose Injection Type Introduction
- 4.1.1 500 mL
- 4.1.2 250 mL
- 4.1.3 1000 mL
- 4.2 Global 5% Dextrose Injection Sales by Type
- 4.2.1 Global 5% Dextrose Injection Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global 5% Dextrose Injection Sales by Type (2021-2032)
- 4.2.3 Global 5% Dextrose Injection Sales Market Share by Type (2021-2032)
- 4.3 Global 5% Dextrose Injection Revenue by Type
- 4.3.1 Global 5% Dextrose Injection Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global 5% Dextrose Injection Revenue by Type (2021-2032)
- 4.3.3 Global 5% Dextrose Injection Revenue Market Share by Type (2021-2032)
5 5% Dextrose Injection Market by Application
- 5.1 5% Dextrose Injection Application Introduction
- 5.1.1 First-Aid Treatment
- 5.1.2 Sports
- 5.1.3 Trophotherapy
- 5.1.4 Others
- 5.2 Global 5% Dextrose Injection Sales by Application
- 5.2.1 Global 5% Dextrose Injection Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global 5% Dextrose Injection Sales by Application (2021-2032)
- 5.2.3 Global 5% Dextrose Injection Sales Market Share by Application (2021-2032)
- 5.3 Global 5% Dextrose Injection Revenue by Application
- 5.3.1 Global 5% Dextrose Injection Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global 5% Dextrose Injection Revenue by Application (2021-2032)
- 5.3.3 Global 5% Dextrose Injection Revenue Market Share by Application (2021-2032)
6 Global 5% Dextrose Injection Sales by Region
- 6.1 Global 5% Dextrose Injection Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global 5% Dextrose Injection Sales by Region (2021-2032)
- 6.2.1 Global 5% Dextrose Injection Sales by Region (2021-2026)
- 6.2.2 Global 5% Dextrose Injection Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America 5% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America 5% Dextrose Injection Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe 5% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe 5% Dextrose Injection Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific 5% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific 5% Dextrose Injection Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa 5% Dextrose Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa 5% Dextrose Injection Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global 5% Dextrose Injection Revenue by Region
- 7.1 Global 5% Dextrose Injection Revenue by Region
- 7.1.1 Global 5% Dextrose Injection Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global 5% Dextrose Injection Revenue by Region (2021-2026)
- 7.1.3 Global 5% Dextrose Injection Revenue by Region (2027-2032)
- 7.1.4 Global 5% Dextrose Injection Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America 5% Dextrose Injection Revenue (2021-2032)
- 7.2.2 North America 5% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe 5% Dextrose Injection Revenue (2021-2032)
- 7.3.2 Europe 5% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific 5% Dextrose Injection Revenue (2021-2032)
- 7.4.2 Asia-Pacific 5% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa 5% Dextrose Injection Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa 5% Dextrose Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Pfizer
- 8.1.1 Pfizer Company Information
- 8.1.2 Pfizer Business Overview
- 8.1.3 Pfizer 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Pfizer 5% Dextrose Injection Product Portfolio
- 8.1.5 Pfizer Recent Developments
- 8.2 Fresenius Kabi
- 8.2.1 Fresenius Kabi Company Information
- 8.2.2 Fresenius Kabi Business Overview
- 8.2.3 Fresenius Kabi 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Fresenius Kabi 5% Dextrose Injection Product Portfolio
- 8.2.5 Fresenius Kabi Recent Developments
- 8.3 Baxter
- 8.3.1 Baxter Company Information
- 8.3.2 Baxter Business Overview
- 8.3.3 Baxter 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Baxter 5% Dextrose Injection Product Portfolio
- 8.3.5 Baxter Recent Developments
- 8.4 Schwitz Biotech
- 8.4.1 Schwitz Biotech Company Information
- 8.4.2 Schwitz Biotech Business Overview
- 8.4.3 Schwitz Biotech 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Schwitz Biotech 5% Dextrose Injection Product Portfolio
- 8.4.5 Schwitz Biotech Recent Developments
- 8.5 Sanbao (GH) Pharmaceutical
- 8.5.1 Sanbao (GH) Pharmaceutical Company Information
- 8.5.2 Sanbao (GH) Pharmaceutical Business Overview
- 8.5.3 Sanbao (GH) Pharmaceutical 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sanbao (GH) Pharmaceutical 5% Dextrose Injection Product Portfolio
- 8.5.5 Sanbao (GH) Pharmaceutical Recent Developments
- 8.6 Otsuka Pharmaceutical
- 8.6.1 Otsuka Pharmaceutical Company Information
- 8.6.2 Otsuka Pharmaceutical Business Overview
- 8.6.3 Otsuka Pharmaceutical 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Otsuka Pharmaceutical 5% Dextrose Injection Product Portfolio
- 8.6.5 Otsuka Pharmaceutical Recent Developments
- 8.7 Drugfield Pharmaceuticals Limited
- 8.7.1 Drugfield Pharmaceuticals Limited Company Information
- 8.7.2 Drugfield Pharmaceuticals Limited Business Overview
- 8.7.3 Drugfield Pharmaceuticals Limited 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Drugfield Pharmaceuticals Limited 5% Dextrose Injection Product Portfolio
- 8.7.5 Drugfield Pharmaceuticals Limited Recent Developments
- 8.8 B. Braun Medical Inc
- 8.8.1 B. Braun Medical Inc Company Information
- 8.8.2 B. Braun Medical Inc Business Overview
- 8.8.3 B. Braun Medical Inc 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 B. Braun Medical Inc 5% Dextrose Injection Product Portfolio
- 8.8.5 B. Braun Medical Inc Recent Developments
- 8.9 Alfa Laboratories
- 8.9.1 Alfa Laboratories Company Information
- 8.9.2 Alfa Laboratories Business Overview
- 8.9.3 Alfa Laboratories 5% Dextrose Injection Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Alfa Laboratories 5% Dextrose Injection Product Portfolio
- 8.9.5 Alfa Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 5% Dextrose Injection Value Chain Analysis
- 9.1.1 5% Dextrose Injection Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 5% Dextrose Injection Production Mode & Process
- 9.2 5% Dextrose Injection Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 5% Dextrose Injection Distributors
- 9.2.3 5% Dextrose Injection Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst